Drug Type Small molecule drug |
Synonyms Inulin (JAN/USP), Inulead + [1] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (30 Apr 1940), |
Regulation- |
Start Date01 Oct 2024 |
Sponsor / Collaborator |
Start Date01 Aug 2024 |
Sponsor / Collaborator |
Start Date10 Apr 2024 |
Sponsor / Collaborator Wuhan Union Hospital [+1] |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diagnostic agents | JP | 11 Oct 2005 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Phase 4 | 40 | (Vitamin D3 and Inulin) | vaammljthv(zrfjctfgrc) = bftyuxpmdz ocyeyrqtxy (mopkqeutqq, zrguusquck - idjnitdohg) View more | - | 07 Feb 2024 | ||
Placebo Inulin+Vitamin D3 (Vitamin D3 and Placebo Inulin) | vaammljthv(zrfjctfgrc) = utnjxjknzs ocyeyrqtxy (mopkqeutqq, tydpotdskz - erciamegnv) View more | ||||||
Phase 2 | 45 | Placebo | cemmodwleu(kjhqbccchb) = nugdkxunlp pjkumdoeja (pbdtlocmul, jncntpkqit - rowcpnmagz) View more | - | 19 Aug 2020 | ||
Not Applicable | 133 | Inulin supplementation | kvkxylqoio(rbmmqirpkr) = rlqlzmdcda muuvxoylex (vsxecewidw ) View more | Positive | 03 Nov 2015 | ||
rgtkvpvmhh(woyoevxlva) = jdnlndcjib aauodsnubh (uszxwnxfrm ) | |||||||
Phase 2 | 85 | laboratory biomarker analysis+atorvastatin calcium (Arm I (Atorvastatin Calcium)) | lrzwcugroz(azifbuillq) = zqrbysdgiw srzsvpirru (glpinkuudq, jtswxwqbht - zwyhxspneh) View more | - | 08 Feb 2013 | ||
laboratory biomarker analysis+sulindac (Arm II (Sulindac)) | lrzwcugroz(azifbuillq) = qvjpdeheeu srzsvpirru (glpinkuudq, nnnuqlctjr - nhdygkrbhz) View more | ||||||
Not Applicable | 32 | bmrijfjdcp(lxcqpnihcn) = zcighyunjg xulbipizmu (ovdshegugg, 8.0%, 28.9%) | - | 01 Aug 2012 | |||
Placebo | bmrijfjdcp(lxcqpnihcn) = qbngtjnuyt xulbipizmu (ovdshegugg, 8.1%, 24.3%) |